Parkinson's Disease Related Molecules
Parkinson's disease is an age-dependent neurodegenerative disease. Symptoms of Parkinson's disease include resting tremor, rigidity, bradykinesia, gait dysfunction and postural instability. Pathologically, the condition is defined by loss of dopamine neurons in the substantia nigra. In addition, the brains of Parkinson's disease patients are characterized by Lewy bodies, intra-neuronal accumulations of insoluble proteins. R&D Systems offers products to study alpha-synuclein, parkin, dopamine and much more.
- Apolipoprotein E/ApoE
- Calbindin D
- Catechol O-Methyltransferase (COMT) Inhibitors
- CDK5
- CDNF
- COMT
- DARPP-32
- Dopa Decarboxylase/DDC
- Dopamine beta-Hydroxylase
- Dopamine D1R/DRD1
- Dopamine D2 R/DRD2
- Dopamine D3 R/DRD3
- Dopamine D5R/DRD5
- FBXO7
- GDNF
- GLUD1/GLUD2
- Glutamate Dehydrogenase 1/GLUD1
- Glutamate Dehydrogenase 2/GLUD2
- HTRA2/Omi
- LRRK2
- MAO-A
- Miro1/Rhot1
- Mitofusin 1
- Mitofusin 2
- N-Me-6,7-diOH-TIQ
- NF-H
- NF-L
- NF-M
- Nicotinamide N-Methyltransferase/NNMT
- p53
- Park7/DJ-1
- Parkin
- PINK1
- PNMT
- Pyridoxal Kinase/PDXK
- Sirtuin 1/SIRT1
- Sirtuin 2/SIRT2
- Sirtuin 3/SIRT3
- Sirtuin 5/SIRT5
- SLC6A3/DAT1
- SMPD1
- alpha-Synuclein
- TMEM106B
- TOR
- Transglutaminase 7/TGM7
- Tyrosine Hydroxylase
- UBE2K/E2-25K
- Ubiquilin 1
- Ubiquitin
- Ubiquitin/Ubiquitin+1
- Ubiquitin+1
- UCH-L1/PGP9.5
- UCH-L3
- USP24
- USP30
- VCP
- VGF
- VMAT2
- ZSCAN21